section 8
on 05 Oct 2012
Last Applicant/ Owned by
103-113 Stanley Street
West Melbourne
AU
3003
Serial Number
78288099 filed on 15th Aug 2003
Registration Number
3062095 registered on 28th Feb 2006
Filing Basis
1. intent to use
Disclaimer
NO DATA
Pharmaceutical and veterinary preparations for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for transdermal delivery for the treatment of sRead More
Pharmaceutical and veterinary preparations for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for transdermal delivery for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for transmucosal delivery for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for hormone-replacement therapy; pharmaceutical compositions containing active agents for the treatment of diseases and conditions of the central nervous system; pharmaceutical compositions for non-occlusive transdermal and transmucosal delivery which form a reservoir or deposit within the skin or membrane for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions providing transdermal and transmucosal delivery of hormones such as estradiol and other physiologically active agents acting on the central nervous system such as fentanyl
No 78288099
No Service/Collective Mark
No 025217-0215
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
05th Oct 2012 | CANCELLED SEC. 8 (6-YR) |
28th Feb 2006 | REGISTERED-PRINCIPAL REGISTER |
06th Dec 2005 | PUBLISHED FOR OPPOSITION |
16th Nov 2005 | NOTICE OF PUBLICATION |
14th Oct 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
16th Sep 2005 | ASSIGNED TO LIE |
10th Sep 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
09th Sep 2005 | TEAS/EMAIL CORRESPONDENCE ENTERED |
06th Sep 2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
06th Sep 2005 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |